Get 250+ investors tailored to your startup

Invest in your industry and stage
Emails & contact info included
Excel and CSV export
Automatically

Trusted by 3,000+ startups

Top 50 Life Science VC (Venture Capital) Funds in Middle East in February 2025

Last updated: Feb 2025 A list of 50 VC (Venture Capital) funds that invest in Life science startups based in Middle east. We rank investors based on the number of investments they made in Life science companies from Middle east. We update this investor list every month.

Top 50 Life Science VC (Venture Capital) Funds in Middle East in February 2025

Investor	Life Science Middle East investments
Sapir Venture Partners	4
Integra Holdings	4
Egypt Ventures	4
TRANGELS	4
Israel Innovation Authority	3
Neo Ventures	3
OrbiMed	3
Pitango VC	3
Johnson & Johnson Robotics and Digital Solutions	2
Takeda Ventures	2
SOSV	2
PeakBridge	2
LoftyInc Capital	2
aMoon Fund	2
Grove Ventures	2
FutuRx	2
Genesis Park	2
Endure Capital	2
fresh.fund	2
Minrav	2
Cairo Angels	2
Oryx Fund	2
First Star Ventures	2
Cancer Focus Fund	2
Arancia International	2
Averroes Ventures	2
Pontifax	2
Trendlines Group	1
Arc Impact	1
Remiges Ventures	1
Milk and Honey Investments	1
M Ventures	1
HBL Hadasit Bio Holdings	1
RMGP Biopharma Investment Fund	1
Aries Holding BV	1
Ibtikar Fund	1
Jerusalem Venture Partners (JVP)	1
Boehringer Ingelheim Venture Fund	1
Trust Ventures	1
Almoayed Ventures	1
RM Global Partners	1
Knuru Capital	1
Fark Labs	1
Forbion Capital Partners	1
Sectoral Asset Management	1
OTV	1
Khwarizmi Ventures	1
Hult Alumni Angels	1
Arba Finance Ltd.	1
Rationalwave Capital Partners	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Early Stage VC

Investment focus

Software, Biotechnology, Machine Learning
Seed, Pre-Seed, Series A
Israel, United States, United Kingdom

Portfolio highlights

Enzymit — Enzymit's platform technology can build molecular machines that enable never before seen chemistry aiming to solve humanity's greatest challenges
Lidwave — Lidwave’s deep-tech solution revolutionizes 3D sensing and the verticals relying on it by examining the biggest challenge in LiDAR technology from a new perspective, free of bandwidth limitations.
DeepCure — DeepCure is a Boston-based therapeutics company that harnesses advanced AI, physics-based tools and automation to discover novel small molecules for challenging targets. DeepCure currently has a lead asset in IND-enabling studies and other programs focused on drugging intractable targets that have t

Our expert team is the first to examine and evaluate the Hebrew University's biomedical breakthroughs. We then capitalize decades of experience - transforming the inventions into pioneering companies. Our golden eggs Ayana Pharma A late stage company with

Investment focus

Biotechnology, Pharmaceutical, Life Science
Seed, Series B, Series F
Israel

Portfolio highlights

BacoCure — BacoCure is developing a novel bacterial product for local therapy of non-muscle invasive bladder cancer (NMIBC) patients.
Splisense — Splisense is develops antisense oligonucleotide based therapies to target genetic diseases caused by splicing mutations. The company has developed a compound to cure the lung disease in cystic fibrosis patients carrying a specific splicing mutation. It is also developing a targeted modulation approach to correct the splicing pattern of CFTRtranscripts according to the specific mutation carried.
Rebiotic Rx — Develops nanotechnology-based antibiotics with the focus on resistant bacteria

Egypt Ventures is an investment firm that empowers the entrepreneurial ecosystem by investing in accelerators. The firm was founded in 2017 and is based in Columbia.

Investment focus

Software, Information Technology, E-Commerce
Seed, Pre-Seed, Series A
Egypt, United States, The Netherlands

Portfolio highlights

Educatly — We help you get into the University of your dreams. We are the only platform with all the information you need to Study Abroad
Gahez Market — Gahez Market Online store
Synapse Analytics — We build data science and AI solutions for streamlined operations and data driven decisions. Synapse Analytics, enabling a smarter world.

Early Stage Investment Fund and Network

Investment focus

Biotechnology, Energy, Manufacturing
Seed, Pre-Seed, Angel
Turkey, United States, Estonia

Portfolio highlights

& New Me — Explore the best aesthetic treatments in Turkey with New Me. Book a consultation, read reviews, and find the right doctor for your beauty journey.
Winfluencer — Winfluencer is a platform for automated digital influencer marketing. Their solutions are machine learning, augmented reality, image processing, data analytics, social media analytics, and fraud detection. Winfluencer connects thousands of e-commerce sites through a single platform and an automated system. Because of the new generation affiliatemarketing approach, this system enables users to generate long-term income. Its transparent structure allows both users and the e-commerce site to track sales generated by their interactions.
Nanomik Biotechnology — Biochemistry leading change in life sciences. With our proprietary technologies, we develop solutions for Crop Health, Animal Health and Food preservation.

The Israel Innovation Agency, the Innovation Authority, was established in 1965 as the Office of the Chief Scientist of the Ministry of Industry and Trade and was designed as a body that supports R & D conducted in the framework of government research institutes. Industrial development in order to increase industrial exports of high-techproducts. The Chief Scientist focused on reducing the risk by participating in financing the project, which the private companies chose and led.

Investment focus

Health Care, Medical Device, Biotechnology
Grant, Seed, Pre-Seed
Israel, United States, Mali

Portfolio highlights

Lidwave — Lidwave’s deep-tech solution revolutionizes 3D sensing and the verticals relying on it by examining the biggest challenge in LiDAR technology from a new perspective, free of bandwidth limitations.
i-EcoGuard — I-Ecoguard is pioneering sustainable agriculture with cutting-edge nanoparticle technology. Our objective is to improve greenhouse efficiency, plant health, and crop quality.
Eretz Angels — Eretz Angels supports technology startups in Israel's outskirts at the start of their journey.

Neo Ventures is the first open-ended early stage investor, based in Eastern Europe. The founders have backed more than 30 startups and exited 10 successfully. We invest in game-changing businesses, without geographic limitations. We partner with exceptional founder teams to challenge incumbents in markets ripe for change or to create entirely newmarkets. Neo Ventures funds and then supports the founders in business planning, scaling operations, follow-on investments, making the best of each opportunity and dealing with hard situations. Our investment focus is on data analytics, computer vision and remote sensing addressing disruptive opportunities across the high-growth SpaceTech, BioTech and Security verticals.

Investment focus

Software, Artificial Intelligence, Aerospace
Seed, Funding Round, Series A
Israel, United Kingdom, Estonia

Portfolio highlights

EnduroSat — At EnduroSat, we engineer, build and operate exceptional satellites. Our Mission is to make space universally accessible
Cyberwrite — TRUSTED BY INDUSTRY LEADERS One platform to accelerate value across the cyber insurance lifecycle THE LATEST FROM CYBERWRITE
GemmaCert — The easy-to-use GC-PRO by GemmaCert for quick and accurate potency analysis of cannabis and hemp, including for THC, CBD, and CBG.

Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.

Investment focus

Biotechnology, Health Care, Medical
Series B, Series A, Series C
United States, China, Israel

Portfolio highlights

Aerin Medical — Aerin Medical offers VivAer for nasal airway obstruction treatment and RhinAer for chronic runny nose treatment. Lasting relief when other solutions fall short.
Stairway Medical — Stairway Medical is a developer of implantable brain-computer interface technology.
Helicore Biopharma — Helicore Biopharma is at the forefront of developing cutting-edge treatments for obesity and related disorders.

Pitango VC is a venture capital firm focused on health-tech (Pitango Health-tech) and growth (Pitango Growth) investments in startups around the world in domains such as vertical SaaS, digital health, deep tech, fintech and insurance technology, devops, generative AI, Web3, and food tech.With two offices in Israel, Pitango currently managesseveral venture funds totaling over $2.8 billion in committed capital. It has invested in more than 250 companies.

Investment focus

Software, Health Care, Information Technology
Series A, Series B, Series C
Israel, United States, China

Portfolio highlights

Homethrive — Homethrive is dedicated to helping families care for their loved ones who are aging or have special needs. Discover how our caregiving solution, Dari, can help you!
Guardoc Health — Streamlining clinical compliance with AI-driven accuracy in charting to meet regulations, enhance patient care, and optimize revenue management.
Quantum Source — Quantum Source is on a clear path to the most powerful, cost-effective, practical photonic quantum computer. Learn more.

Healthcare innovation wherever it originates.

Investment focus

Biotechnology, Health Care, Medical
Series A, Series B, Series C
United States, Israel, United Kingdom

Portfolio highlights

Moon Surgical — Create the OR of the future, one that is sustainable, efficient, and digitalized.
Artera — Discover the power of Personalized Precision Medicine & AI Cancer Therapy with Artera. Transforming cancer therapy through innovation.
ONL Therapeutics — ONL Therapeutics develops innovative therapeutics to protect and improve the vision of patients with a range of retinal diseases and conditions.

Takeda Ventures, Inc. (TVI) is the corporate investment arm of Takeda Pharmaceutical Company Limited (TPC). TVI was founded in 2001 and invests in current and future areas of interest for TPC. They are based alongside Takeda’s R&D sites in Cambridge, MA, and San Diego, CA. As a strategic investor, TVI aims to provide support and guidance toentrepreneurs and early-stage companies driving concepts through clinical proof of concept. They also strive to forge active, collaborative interactions that result in synergies with Takeda's considerable R&D resources. Their goal is to build a portfolio of strategic investments, with an immediate emphasis on oncology, gastroenterology, neuroscience, and rare diseases.

Investment focus

Biotechnology, Health Care, Therapeutics
Series A, Series B, Funding Round
United States, United Kingdom, Israel

Portfolio highlights

Be Biopharma — Be Bio is developing a proprietary class of engineered B cells as medicines that unleash the potential of cell therapies in applications beyond cytotoxicity.
Larkspur Biosciences — Larkspur's strategy focuses on the particular ways in which tumours hijack the immune system by developing precision immunotherapies for molecularly defined patient groups to overcome the bottlenecks that allow the tumour to subvert the immune system.
EvolveImmune Therapeutics — EvolveImmune Therapeutics transforms the discovery and development of novel immunotherapies. By leveraging its proprietary in vivo target discovery platform, EvolveImmune is building a pipeline of novel therapeutic candidates against numerous targets that are expressed on multiple immune cell types. The company’s platform will generatefirst-in-class treatments for unmet needs in oncology and autoimmune diseases.

SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.

Investment focus

Biotechnology, Health Care, Software
Seed, Convertible Note, Pre-Seed
United States, India, United Kingdom

Portfolio highlights

MixRift — MIXRIFT - game developers specialized in Mixed Reality
unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.

PeakBridge is a global impact VC that funds and connects the people, technology and processes that will shape the future of food.

Investment focus

Food and Beverage, Food Processing, Health Care
Series A, Seed, Funding Round
Israel, United States, United Kingdom

Portfolio highlights

BE WTR — The first premium sustainable water brand aiming to promote a more ecological water consumption and to contribute to a better hydration thanks to its technological and design water systems. | Discover more about us.
Mondra — AI-driven environmental insights platform that supports food system players to accelerate Scope 3 progress, reduce the cost of Net Zero, and drive competitive advantage.
Orbisk — One-third of all food produced (worldwide) is wasted. Orbisk helps professional kitchens to get a grip on their food waste.

LoftyInc Capital Management empowers Afropreneurs to build a prosperous and equitable future in Africa. We deliver value to both founders and investors.........

Investment focus

FinTech, Financial Services, Software
Seed, Pre-Seed, Series A
Nigeria, United States, Egypt

Portfolio highlights

Mtor — Mtor is an online marketplace that is reshaping the automotive aftermarket and provides sophisticated technology solutions.
EMTECH — EMTECH provides solutions for Digital Currency regulatory compliance, development and management to help Central Banks and FinTechs build, run and manage modern financial systems.
Terragon Group — Terragon is a leading Data and Marketing Technology company that uses data and analytics to help companies focused in Africa, intelligently connect at scale to their customers. We use an aggregation of online and offline data, and predictive scoring to help brands, marketing agencies and platforms accurately target people across channels anddevices. Headquartered in Lagos; Nigeria, we also have a presence in Kenya, South Africa, Ghana and India.

aMoon is a leading healthtech & life sciences venture capital firm.

Investment focus

Health Care, Biotechnology, Medical
Series B, Series A, Funding Round
United States, Israel, Switzerland

Portfolio highlights

Lyfegen — Lyfegen is the first of its kind, a company making value-based healthcare contracting for high-cost therapies a reality for all healthcare stakeholders.
PrognomiQ — PrognomiQ is invested in transforming the detection and early treatment of cancer and other complex diseases. Learn more about our test products and careers.
MetaSight Diagnostics — MetaSight Diagnostics, a health technology company, is on a mission to develop affordable and precise liquid biopsy diagnostics for the early detection of a wide range of chronic and acute diseases by leveraging proprietary mass spectrometry technologies (metabolomics, lipidomics, and proteomics).

Grove Ventures is a leading early-stage venture capital fund in Israel. It partners early with exceptional Israeli founders who believe th...

Investment focus

Artificial Intelligence, Machine Learning, Software
Seed, Series A, Series B
Israel, United States

Portfolio highlights

Enzymit — Enzymit's platform technology can build molecular machines that enable never before seen chemistry aiming to solve humanity's greatest challenges
Wing Cloud — Wing Cloud tames cloud complexity through a unified programming and operational model that works across all providers and services.
Quantum Source — Quantum Source is on a clear path to the most powerful, cost-effective, practical photonic quantum computer. Learn more.

FutuRx is the Israeli biotechnology accelerator that was established in 2014 by OrbiMed Israel Partners, Johnson & Johnson Innovation and Johnson & Johnson Development Corporation (JJDC) and Takeda Ventures Inc. following winning the tender of the Office of the Chief Scientist (OCS), Ministry of Economy, in Israel.The incubator willadvance new biotechnology products by identifying and nurturing early-stage life science innovation.FutuRx is located in the Weizmann Science Park in Ness Ziona (near the Weizmann Institute), Israel.

Investment focus

Biotechnology, Life Science, Biopharma
Seed, Funding Round
Israel

Portfolio highlights

Ramino Bio — Ramino Bio is a private biotech company that develops an oral drug to treat metabolic diseases.Ramino has received funding totaling about $3.3 million since its beginning from the FutuRx biotech incubator, which is supported by the Israeli Innovation Authority, Takeda, J&J, OrbiMed, and RMPG. By speeding up their disintegration, our exclusivetechnology lowers the extra BCAA that is floating around.
Protekt Therapeutics — ProteKt Therapeutics is a drug development company aiming to develop potent and selective oral inhibitors of the kinase PKR for the treatment of neurodegenerative and neuroinflammatory diseases. The company has raised a $4M pre-A round and graduated from the FutuRx accelerator in 2019.
Bsense Bio Therapeutics — Bsense Bio Therapeutics is developing small molecules for the treatment of neuropathic pain. Bsense is pioneering a novel approach targeting multiple pain-related mechanisms using a single compound, to achieve greater efficacy and safety.

Genesis Park is a Houston-based private equity firm focusing on buyouts, partnering strategies with public corporations, and growth financing. We bring capital, commercial execution capabilities and a depth of experience in mergers and acquisitions.We are opportunistic within market sectors where we have depth and exposure. Those sectors includetelecommunications, energy technology and media. Energy technology is a rapidly expanding category, and our Houston base allows us to marry traditional and alternative techniques in upstream and downstream environments. Founded in 2000, Genesis Park has used discipline and patience to build value for our investors, regardless of prevailing market conditions. We are consistently active in our portfolio companies, listening, learning and adding value by working alongside management. While our preference is to partner with an existing management team, we commonly source additional talent to optimize the existing opportunity.

Investment focus

Manufacturing, Construction, Health Care
Private Equity, Debt Financing, Funding Round
United States, Israel

Portfolio highlights

The Good Feet Store — Discover comfort and foot pain relief with The Good Feet Store arch support inserts. Clinically proven - improve body alignment and overall foot health.
WESTCO GROUNDS — Westoco Provides Landscaping is a highly competitive industry, and Westco continues to thrive because it tailor services to specific client needs and deliver complete solutions with dependability,Rainbird facilitate quick responses and ressources.
Conditioned Air — Conditioned Air is South Florida's premier air conditioning contractor with 60 years of experience. Serving Naples, Venice, Ft. Myers, Englewood, Port Charlotte, Sarasota, Bradenton & Surrounding Areas.

Endure Capital is an early stage investment fund headed by entrepreneurs looking for startup teams. They look for founders who are relentlessly resourceful and imaginative, solving genuine problems that matter to a lot of people and building high growth companies that endure.

Investment focus

Software, Health Care, Artificial Intelligence
Seed, Series A, Series B
Egypt, United States, United Kingdom

Portfolio highlights

Pyka — We believe that electrification and automation will make aviation safer, more affordable, and more accessible than has ever been possible in human history.
ShopLook — Online personal styling destination. Discover outfit ideas or virtually create your own using our outfit maker.
Cash Cows — Cash Cows helps startups hone their operations and strategies so they can expand profitably and create better brands. They collaborate with customers to close the gap between traditional business practices (experience) and cutting-edge approaches (solutions), allowing companies to operate successfully.

fresh.fund is an Israeli pre-seed venture capital fund investing in early-stage startups across segments and verticals.We're built to partner with early-stage founders from day one, often as the company's first institutional investors. Our model is refreshingly simple: up to $300,000 in pre-seed funding within <4 weeks and follow-oncapital as necessary.Check out our portfolio here >> https://www.fresh.fund/portfolio. It's never too early to have a conversation about your startup.

Investment focus

Health Care, FinTech, Education
Seed, Pre-Seed, Series A
Israel, United States, Norway

Portfolio highlights

enso — enso offers AI-powered bot bundles to automate your marketing strategy. Perfect for small business owners, our bots handle social media, SEO, lead generation & much more. Start with a 7 days free trial or talk with one of our marketing experts today.
Carbon Blue — Carbon Blue is developing an 'ocean-capture' scalable method for removing CO2 from the atmosphere. The company was founded by Iddo Tsur and Dan Deviri.
Guardoc Health — Streamlining clinical compliance with AI-driven accuracy in charting to meet regulations, enhance patient care, and optimize revenue management.

Minrav provides engineering and construction services.

Investment focus

Health Care, Hospital, Wellness
Series A, Funding Round
Israel, Malaysia

Portfolio highlights

iwi Life — Algae is the ultimate source of Omega-3s. Research has proven that Omega-3s support cardiovascular health, a balanced mood, and healthy brain development.
Qualitas Health — Qualitas Health Group aims to serve patients through a network of 500 clinics by 2022 with quality healthcare services across the Asia Pacific.

Cairo Angels is an angel investment network that invests in and supports early-stage startups it convenes regular investment meetings to review pre-selected potential investees.

Investment focus

E-Commerce, Mobile, Marketplace
Seed, Angel, Pre-Seed
Egypt, United States, Lebanon

Portfolio highlights

Nawah Scientific — Nawah is MENA & Africa's first Cloud Lab providing Analytical and R&D services to the region's life science, food, agricultural and pharmaceutical sectors.
Sprints — home page Description
The Fashion Kingdom — Fashion, Sneakers for men, women, and kids

Oryx Fund is a MENA-focused Investment fund from Hambro Perks. Investing in game-changing early-stage technology companies at late Seed and Series A, led by outstanding entrepreneurs in sectors we have deep expertise such as Fintech, Healthtech, Enterprise tech, Logistics tech, and Edtech.

Investment focus

Software, Information Technology, SaaS
Seed, Pre-Seed, Series A
United Arab Emirates, Saudi Arabia, Egypt

Portfolio highlights

Ejari — Ejari is providing a Rent Now, Pay Later (RNPL) solution for residential rentals, Rent Now, Pay Later products enable tenants to better manage their budgets by converting rent from a yearly expense to a monthly expense, while landlords receive an entire year's rent in advance.
Growdash — Growdash is a business intelligence and analytics tool built specifically for restaurants to support profitable growth strategic decisions across online sales channels.
GrubTech — An end-to-end kitchen management platform with food aggregator, online ordering, POS, ERP and 3pl integrations; to streamline online food delivery orders and create efficiencies for delivery-centric restaurants and cloud kitchens (ghost kitchens, dark kitchens, virtual kitchens).

Investing with conviction in visionary, technical founders inventing the future.

Investment focus

Software, Artificial Intelligence, Biotechnology
Seed, Pre-Seed, Series A
United States, Canada, Israel

Portfolio highlights

Enzymit — Enzymit's platform technology can build molecular machines that enable never before seen chemistry aiming to solve humanity's greatest challenges
Bot Auto — Bot Auto develops and operates autonomous trucks for middle-mile freight.
Phaseshift Technologies — Phaseshift Technologies is developing a Computational Materials Engineering (CME) platform to help accelerate the Research and Development of High-Performance Alloys. The CME platform is driven by Quantum Chemistry calculations and aided by Machine Learning based predictive algorithms.

Cancer Focus Fund is an investment firm that is dedicated to providing financial services to its clients. The company was founded by Ross Barrett.

Investment focus

Biotechnology, Medical, Health Care
Funding Round, Seed, Series A
Israel, United States, Germany

Portfolio highlights

Eisbach Bio — Eisbach Bio is a biotechnology company that creates new drugs that target molecular vulnerabilities in cancer genomes. Screening and cellular platforms are yielding first-in-class inhibitors to directly target the key vulnerability found in genetically defined tumors. It is founded in 2019 and is based in Martinsried, Bavaria.
March Biosciences — Transforming Patient Care by Unlocking New Target Spaces March Biosciences is a clinical-stage company in the cell therapy field focused on developing CAR-T cell strategies to address the most challenging hematological cancers Pipeline MB-105 https://march.bio/wp-content/uploads/2023/05/shutterstock_1008023995-HD-30.mp4 Focused on Excellence Target Space Our approach combines biological and engineering insights to enable target-unlock without the risk and complexity
Starget Pharma — Starget Pharma develops a new generation of targeted radiopharmaceutical technologies for the treatment of solid tumors. Starget Pharma has a pipeline of novel targeted radiopharmaceutical molecules that act as a vector for selectively transferring radioisotopes to cancer tumor tissues.

Arancia International Inc is a part of Arancia Group in Mexico. We are long term investors in food, nutrition and biotechnology companies.

Investment focus

Health Care, Biotechnology, Life Science
Series A, Series B, Funding Round
Israel, United States, Malaysia

Portfolio highlights

NextFerm — NextFerm is a science oriented industrial company, representing a new era in fermentation and fermentation-derived nutrients for supplements, food, infant nutrition and animal feed.The world is striving for better nutrition. Nutrition which is less artificial and more natural, sustainable and cost effective - with a much higher nutritional value.At Nextferm, they aim to use their capabilities to lead this new and exciting world of better nutrition.
iwi Life — Algae is the ultimate source of Omega-3s. Research has proven that Omega-3s support cardiovascular health, a balanced mood, and healthy brain development.
The Mediterranean Food Lab — The Mediterranean Food Lab merge traditional fermentation and cutting-edge science, to produce natural plant-based flavor-bases for a wide range of meat replacement needs.

Averroes Ventures helps and invests in entrepreneurial teams seeking to transform big ideas into game-changing companies. Averroes Ventures' team possesses years of combined experience in global business operation and management across a multitude of sectors to help achieve visions.

Investment focus

Transportation, Logistics, Delivery
Seed, Convertible Note
Egypt, United Arab Emirates

Portfolio highlights

ILLA — Digital trucking and delivery platform powered by reliable drive to enable businesses with different volumes handle and optimize their trucking and logisitcs processes effeciently.
Nawah Scientific — Nawah is MENA & Africa's first Cloud Lab providing Analytical and R&D services to the region's life science, food, agricultural and pharmaceutical sectors.
Khazenly — Khazenly is an on-demand digital warehousing and fulfillment management platform that provides an omnichannel solution to help merchants digitize their businesses.

Pontifax is a healthcare-dedicated venture capital firm.The fund focuses on innovative bio-pharma opportunities.

Investment focus

Biotechnology, Health Care, Therapeutics
Series A, Series B, Series C
United States, Israel, France

Portfolio highlights

ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
Adcytherix — Adcytherix is a biopharmaceutical company focused on the development of novel antibody drug conjugates (ADC) to treat high unmet need diseases such as cancer.
Indapta Therapeutics — Indapta Therapeutics is a privately held biotechnology company developing an NK (natural killer) cell therapy platform for the treatment of blood and solid tumor cancers.

Trendlines Group invents, discovers, invests in, and incubates innovation-based medical and agrifood technologies. Trendlines invests principally through medical and agrifood incubators in Israel and in Singapore, its in-house innovation center, Trendlines Labs, and its Funds - the Trendlines Agrifood Fund and the Bayer Trendlines Ag InnovationFund.The company was founded in 1993 and is headquartered in Misgav, Israel.

Investment focus

Health Care, Biotechnology, Medical Device
Seed, Funding Round, Series A
Israel, Singapore, United Kingdom

Portfolio highlights

Insectta — Insectta was founded in 2017 and produces materials from insects which can be applied across industries such as agrifood, pharmaceutical and electronics.
Celleste Bio — Celleste is a business that specializes in employing cell culture techniques to produce high-value cocoa ingredients, removing the need for cocoa trees to be grown.
ViAqua Therapeutics — ViAqua is developing the first orally administered treatment in aquaculture to stop diseases from developing and to prevent viral epidemics.

Arc Impact is a venture capital firm.

Investment focus

Health Care, Food and Beverage, AgTech
Seed, Pre-Seed
Israel, United States, United Kingdom

Portfolio highlights

Behavidence — Behavidence is a mental health application that generates a daily mental health score. It compares your digital behavior to other people with anxiety, depression and ADHD.
MadeRight — We usher in a new era of sustainable fungi-based materials that deliver excellent performance. The future, as we see it, is a novel industrial chain based on biomaterials.
Virtual Internships — The only platform that provides guaranteed remote internships in your chosen industry and region to gain the skills employers seek.

Remiges Ventures is a venture capital firm that focuses on groups and businesses in the Japanese academia and pharmaceutical industry.

Investment focus

Biotechnology, Health Care, Therapeutics
Series A, Series B, Seed
United States, Japan, Canada

Portfolio highlights

Immunis — Currently seeking participants for age-related muscle atrophy (sarcopenia) clinical trails
Kupando — Kupando is a biopharmaceutical company that develops agonists to stimulates innate immunity.
LUCA Science — LUCA Science develops innovative treatments intended for mitochondrial and related diseases.

The Land of Milk and Honey is an abundant location where life is simple and devoid of need. Both in brand-new real estate development projects and while professionally restoring and renovating houses, Milk and Honey Investments LLC aims to create distinctive spaces of abundance and healthy living.

Investment focus

Life Science, Organic Food, Biotechnology
Series A
Israel

Portfolio highlights

BioBetter — BioBetter is a foodtech company that develops plant-based platforms for the production of complex growth factors used in cultivated meat. The company was founded in 2015 and is headquartered in Israel.

Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.

Investment focus

Biotechnology, Health Care, Therapeutics
Series A, Series B, Seed
United States, Switzerland, United Kingdom

Portfolio highlights

CellFE — CellFE is a company developing a microfluidics based device to deliver gene-editing molecules. CellFE developed microfluidic device and process that can efficiently deliver gene-editing molecules into the human cells.
BeeOLED — BeeOLED’s technology enables OLED displays with significantly improved efficiency, brightness and operational stability at lower overall costs due to a less complex device structure.
Lightcast Discovery — Flexible control over droplet number, occupancy, location and movement. Enabling efficient, multi-step workflows with unprecedented flexibility.

Hadasit Bio-Holdings Ltd. ("HBL") was founded and floated on the Tel Aviv Stock Exchange (TASE : HDST ) and recently on the OTC (OTCBB : HADSY ) in order to allow public participation in the highly promising field of biotechnology.It serves as a precedent in biotech financing - for the first time, public investment is allowed toparticipate in a holding entity including companies based on IP generated by Israel’s foremost medical research center – Hadassah University Hospital ("HU").In addition to the public holdings (54%) – including major Israeli institutional investors, HBL is held by Hadasit (www.hadasit.co.il) (36%) and Consensus Business Group (http://www.consensusbusiness.com) (10%). The traded stock, as a unique investment vehicle, provides investment exposure to a select cluster of 6 biotech companies - all based on inventions developed and owned by HU.HBL is a publicly traded subsidiary of Hadasit Ltd. – the technology transfer company of the Hadassah University Hospital in Jerusalem, Israel. Hadasit was established for the purpose of promoting and commercializing the intellectual property (IP) and R&D capabilities generated by Hadassah, aimed at finding solutions to problems faced by modern medicine.

Investment focus

Biotechnology, Medical, Health Care
Funding Round, Series A, Series B
Israel

Portfolio highlights

ProtAb — ProtAb develops therapeutic agents that modulate cytokine regulation, tipping the balance toward anti-inflammatory signaling pathways in the treatment of autoimmune and inflammatory diseases. Its first product, Prozumab, is a monoclonal antibody with a novel mechanism of action. It is currently in late-stage preclinical development for thetreatment of inflammatory bowel disease or IBD, ulcerative colitis or UC, and rheumatoid arthritis or RA. It operates as a subsidiary of Hadasit Bio-Holdings. HBL is a publicly traded subsidiary of Hadasit, the technology transfer company of the Hadassah University Hospital in Jerusalem in Israel.
KAHR medical — KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders.
Enlivex Therapeutics — Enlivex is a clinical-stage macrophage reprogramming immunotherapy company that targets diseased macrophages in patients with sepsis. The company develops an autologous and allogeneic drug pipeline for the treatment of autoimmune and inflammatory conditions such as Graft versus Host Disease (GvHD), solid organ transplant rejection, Crohn'sDisease, and other autoimmune and inflammatory disorders.The company's revolutionary approach is to induce immune tolerance by injecting apoptotic cells and facilitating their interaction with dendritic cells activates the body's innate, physiologic mechanism for down-regulating inflammation and autoimmunity.Enlivex is an Israeli-based cell immunotherapy company established in October 2005 by Professor Dror Mevorach, a world-renowned expert on clearance of dying (apoptotic) cells.

RMGP Biopharma Investment Fund is an investment Fund

Investment focus

Biotechnology, Biopharma, Health Care
Seed, Series B, Funding Round
Israel

Portfolio highlights

Ramino Bio — Ramino Bio is a private biotech company that develops an oral drug to treat metabolic diseases.Ramino has received funding totaling about $3.3 million since its beginning from the FutuRx biotech incubator, which is supported by the Israeli Innovation Authority, Takeda, J&J, OrbiMed, and RMPG. By speeding up their disintegration, our exclusivetechnology lowers the extra BCAA that is floating around.
Pi Therapeutics — Pi Therapeutics is a discovery-stage biopharmaceutical company aiming to develop a novel cancer drug. The company is financed by a syndicate of Takeda Pharmaceutical Company through its venture group Takeda Ventures Inc., Johnson & Johnson Innovation – JJDC, OrbiMed Israel Partners, Pontifax, and the Israel Innovation Authority, and hasoperated since March 2015 in the FutuRx biotech accelerator in Ness Ziona, Israel. The company’s mission is to develop novel first-in-class drugs directed against the ubiquitin-proteasome system (UPS), mainly for treatment of cancer.
Protekt Therapeutics — ProteKt Therapeutics is a drug development company aiming to develop potent and selective oral inhibitors of the kinase PKR for the treatment of neurodegenerative and neuroinflammatory diseases. The company has raised a $4M pre-A round and graduated from the FutuRx accelerator in 2019.

financial holding company / investments

Investment focus

FinTech, Finance, Payments
Seed, Pre-Seed
The Netherlands, Israel

Portfolio highlights

Wakuli — It's called specialty coffee. Roasted lighter to enhance all the exciting flavours. To really taste them it's important to drink fresh. That's why we send our mailbox-friendly coffee within one week after roasting. And always with a better price for the farmers - thanks to you.
Diptera — Developing technology to fight mosquitoes with mosquitoes.
Flow — Flow is FinTech 3.0: It let's you automate payments between your bank accounts and wallets. Based on triggers and actions you can transfer your money automatically to the accounts you choose. Use Flow to automate a budgetting system, your investing, buying crypto or to distribute your money the way you like it. Where the previous generationpayment companies needed to build and maintain expensive payment rails, Flow focusses on leveraging Open Banking. People trust Flow to help with their cashflow automation.

Ibtikar (Innovation, in Arabic) is a disruptive fund that will invest in innovative Palestinian companies. Ibtikar’s investments begin at the seed level through local accelerators, continue in post-acceleration phases and can also include series A investments in its portfolio companies. Through this investment strategy we aim to close a criticalfunding gap between acceleration and VC and other later-stage investors. Our goal is to maximize return for our investors by helping high-potential Palestinian companies answer regional and global needs. We will do this through direct support from our management team and select group of advisors, and will leverage the strong network of our investors and partners for the benefit of each of our portfolio companies.

Investment focus

Artificial Intelligence, E-Commerce, Information Technology
Seed, Pre-Seed, Funding Round
Palestinian Territory, United States, Jordan

Portfolio highlights

Nabeeh — Nabeeh is an online platform that allows users to book housekeeping, cleaning services, maintenance, repairs, and renovation services.
DataQueue — Discover essential strategies for AI readiness with DataQueue. Learn how to prepare your business, choose the right AI tools, and develop a strategic AI plan for future success
Alma Health — Alma Health is a digitally-native chronic illness management platform serving an addressable market of 20m patients in GCC. Through its cloud pharmacy and virtual doctor consultations, Alma Health is translating patient behavior and insights into personalized services and products like digital treatments and at home monitoring systems. Alma Healthis based in Hub71-Abu Dhabi.

JVP is a top VC firm with $1.9B AUM and 165 companies built, leading in AI, Cyber Security, Fintech, Insurtech and Climatech.

Investment focus

Software, Cyber Security, Enterprise Software
Series A, Series B, Seed
United States, Israel, United Kingdom

Portfolio highlights

Datricks — Offering real-time risk detection and control, ensuring continuous financial compliance and enabling you to significantly impact the bottom line of your business
Greeneye Technology — Spray Less, Grow More. Our mission is to dramatically reduce chemicals usage while increasing productivity and profitability for farmers.
Secret Double Octopus — Provider of industry-leading FIDO-certified, rotation-based passwordless MFA with the fullest support for enterprise complexity. Click here for more!

The Boehringer Ingelheim Venture Fund is the strategic venture fund of the Boehringer Ingelheim Corporation.

Investment focus

Biotechnology, Health Care, Therapeutics
Series A, Series B, Seed
United States, Germany, Belgium

Portfolio highlights

DiogenX — We incorporated DiogenX with the objective to provide new therapeutic solutions for diabetic patients. With Patrick Collombat and the team, we are focused on developing a first-in-class regenerative treatment for type 1 diabetes. Benjamin Charles CEO See the team News See more Our Work OUR APPROACH ABOUT DIABETES
smartbax — We develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug resistant bacteria and difficult-to-treat biofilms.
Rewind Therapeutics — Rewind Therapeutics is a developer of novel therapeutics intended to facilitate the treatment for neurological diseases.The company's first-in-class remyelinating therapeutics block inhibitory signals that prevent the expansion and migration of oligodendrocyte stem cells in order to promote effective remyelination, enabling medicalpractitioners to treat patients suffering from multiple sclerosis and other myelin-related diseases with efficacy.

Trust Ventures is a venture capital firm that focuses on startups and provides knowledge and expertise in incumbent-heavy industries. The firm was founded in 2018 and is based in Austin, Texas, United States.

Investment focus

Information Technology, Health Care, Software
Seed, Series A, Series B
United States, Brazil, Israel

Portfolio highlights

Harbor — Harbor offers the first and only baby monitoring system with a dedicated, local Monitor that works without internet and securely connects to the cloud if and when you want it to, allowing you to access remotely with failsafe notifications. Learn why Harbor is better than Nanit & Owlet at harbor.co!
Valkyrie Andromeda — Andromeda is a decision-intelligence platform that develops unbiased strategic plans and hallucination-free processes based on a single prompt—designed for national security.
GreenLite Technologies — GreenLite makes getting a construction permit fast, predictable, and transparent. Let the GreenLite Platform handle your permitting needs so you can focus on growing your business.

Almoayed Ventures is the venture arm of Almoayed General W.L.L. The company focuses on partnering with investment professionals with a track record of supporting and scaling innovative businesses. The company also makes direct investments in passionate entrepreneurs and supports them throughout their journey.

Investment focus

FinTech, Health Care, Financial Services
Seed, Pre-Seed, Series A
United States, India, Bahrain

Portfolio highlights

BARQ — BARQ enables bullet delivery for any business. From e-commerce to food, e-groceries and various sectors, BARQ utilizes its state-of-the-art delivery technologies to deliver orders as fast as 15 minutes up to same day delivery service.BARQ converts retail outlets to micro-fulfilment centers/dispatching hubs making delivery faster &easier. Once a customer places an order through the business platform, order gets fulfilled by the closest retail outlet and delivered to the customer once ready for pick up (bullet delivery).BARQ also serves warehouses and fulfillment centers with several delivery options, 4hrs up to same day or next day, depending on the business’ need. While restaurants and food aggregators enjoy 30-45 minute delivery service & paying a delivery fee ONLY.
Erad — erad provides growth capital to online businesses. Connect your analytics and receive funding offers, for non-dilutive capital within 48 hours
Unipal — Unipal provides university students access to tailored discounts and promotions through a digital identification.

RM Global is an investment banking and strategic advisory firm dedicated to creating unique value for its clients and investors. We specialize in Life Sciences, including pharmaceuticals, medical devices, biotechnology, healthcare IT/digital health, and diagnostics. Our broad international reach includes the Americas, Europe, Israel, and Asia.Since 1992, our diverse team of accomplished professionals has worked closely with life science companies ranging from start-ups to multinationals, providing unbiased strategic and financial advice, based upon our comprehensive industry experience. Several of our partners were senior management of Roberts Mitani, which completed over $3 billion in M&A and strategic transactions and raised over $200 million in private growth and venture capital for clients. We take pride in our long term relationships with our clients that span many years.We leverage our unique global network of leading corporations, investment funds, institutional and strategic investors, family offices, industry experts and management teams to source and execute transactions that build new opportunities for our clients worldwide.

Investment focus

Biotechnology, Health Care, Life Science
Series A, Series B
Israel, United States

Portfolio highlights

BIOMx — Developing natural and engineered phage therapies to eradicate harmful bacteria in chronic diseases.
Mitoconix Bio — Mitoconix Bio is pioneering a disease-modifying strategy of improving mitochondrial functions for treating neurodegenerative diseases.Mitochondria generates ATP, the energy source for all cellular activities. Mitochondria are also involved in other essential cellular functions, including calcium sequestration, amino acid and lipid metabolism,keeping balanced redox potential and orchestrating programmed cell death. In neurons in particular, mitochondria are very dynamic organelles that constantly undergo fission (division) and fusion. This process, called mitochondrial dynamics, is critical in maintaining healthy and functional mitochondria under both normal conditions and in response to stress and in ensuring having viable mitochondria along the axons and in the synaptic boutons. A defect in either fusion or fission limits mitochondrial motility, decreases energy production, increases oxidative stress and activates pro-apoptotic signaling thereby promoting cell dysfunction and death.Mitoconix’ lead drug is a first-in-class inhibitor of pathological mitochondrial fragmentation and dysfunction with demonstrated in vivo efficacy in animal models of Huntington’s (HD) and Parkinson’s diseases (PD) and beneficial activity in patient-derived cells of HD, sporadic and genetic PD, and sporadic and genetic Alzheimer’s disease (AD).
ImmPACT Bio — ImmPACT Bio USA Inc. is a cell therapy company aiming to develop potent and selective engineered T-cells for the treatment of solid tumors. The Company's technology enables targeting loss-of-gene features of solid tumor cells, sparing normal, healthy tissues.

Based out of Dubai, Knuru pursues equity and credit opportunities in fintech and marketplaces across the GCC, Africa and Southern Europe. The management is led by a team of investors and entrepreneurs bringing to venture capital extensive cross-asset class experience dedicated to supporting high growth businesses.

Investment focus

E-Commerce, Information Technology, Financial Services
Series A, Funding Round, Series C
United Arab Emirates, Spain, Kenya

Portfolio highlights

Savana — Transform EMR into Deep-Real World Evidence with a scientific methodology that applies Artificial Intelligence (AI) to EMR free-text.
Alma Health — Alma Health is a digitally-native chronic illness management platform serving an addressable market of 20m patients in GCC. Through its cloud pharmacy and virtual doctor consultations, Alma Health is translating patient behavior and insights into personalized services and products like digital treatments and at home monitoring systems. Alma Healthis based in Hub71-Abu Dhabi.
The Giving Movement — Sustainable Activewear & Streetwear Clothing | Made in UAE | $4 per item donated to charity | Gym Clothing & Workout Clothes

Fark Labs is a global innovation and transformation hub that aims to build a better future for all. We help entrepreneurs, startups, corporations, and investors transform into more connected, innovative, and future-ready versions of themselves so they have a positive impact on the world. We apply an investment portfolio approach to our innovationstrategy, touching all stages of the startup lifecycle from incubator to investor in Turkey, which is strengthened by our strong global network of regional accelerators and VC partners in our key global geographies. We use this approach for our 4 focus verticals: mobility, life sciences, sustainable lifestyle, and emerging technologies, which we call our curiosity cabinet.We back change-makers who transform industries and create new ones. Our sweet spot is investing early, and we continue to provide support and investment up to Series A. We envision a better future by championing entrepreneurship, innovation, and frontier technologies that transform legacy businesses and build future-proof startups.We also drive innovation and transformation through collaborative intelligence. We build a unique ecosystem that connects difference-makers, leading corporations, venture capital firms, universities, and government agencies across our 4 verticals.

Investment focus

SaaS, Manufacturing, Last Mile Transportation
Seed, Series A, Pre-Seed
Turkey

Portfolio highlights

Evreka — Evreka is a leading SaaS company providing the most comprehensive intelligent solutions designed for the entire category of waste management across the globe.
M-Based — M-based is an initiative aiming to develop eco-friendly alternative material technologies using mycelium, a component of the mushroom. Its R&D efforts focus on developing mycelium-based vegan leather to address environmental concerns and animal ethics violations in the textile industry.
Ion membranes — Ion membranes is a company that designs and manufactures ion exchange membranes and separators for the green energy industry. Our products are used in batteries, electrolyzers, fuel cells, chlor-alkali facilities, electrodialysis water treatment processes, and other applications that require ionic range separation.

Impacting the future of medicine.

Investment focus

Biotechnology, Health Care, Medical
Series B, Series A, Series C
United States, United Kingdom, The Netherlands

Portfolio highlights

Pheon Therapeutics — Pheon Therapeutics is an Antibody-Drug Conjugate (ADC) specialist that creates ADCs for a variety of difficult-to-treat cancers. Its lead program is a first-in-class ADC against a novel target that is highly expressed in solid tumors across a broad range of hard-to-treat cancer types.The company was founded in 2022 and is based in London,England.
Bicycle Therapeutics — Bicycle Therapeutics is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops which stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical need.The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC.
Progentos Therapeutics — Progentos Therapeutics develops an approach to treat multiple sclerosis that stimulates the body's natural repair mechanisms.

Sectoral is specialized in managing equities globally in the healthcare sector. Founded in October 2000, we are SEC-registered as an investment advisor. 100% employee-owned, we have offices in Montreal, Geneva, and Hong Kong.

Investment focus

Biotechnology, Health Care, Medical
Series B, Series C, Post-IPO Equity
United States, United Kingdom, France

Portfolio highlights

CurvaFix — Curvafix is the only intramedullary implant that follows the natural curvature of the pelvis. Continue reading to learn how the Curvafix implant works!
Boundless Bio — Boundless Bio is a company that develops novel cancer therapeutics intended to understand and treat intraceable cancers. It aims to be the foremost biopharma company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable cancers.Boundless Bio was founded in 2018 and isheadquartered in La Jolla, California.
LENZ Therapeutics — LENZ Therapeutics is a late-stage clinical company developing innovative ophthalmic pharmaceutical products that improve vision.

OTV focuses on round A+ startups that aim to make a significant impact on people's lives. Our focus is on entrepreneurs with innovative ideas who are advancing the global state of well-being. Come join the digital health revolution, and be a part of transforming the healthcare industry.

Investment focus

Health Care, Medical, Artificial Intelligence
Series A, Series B, Seed
United States, Israel, Ghana

Portfolio highlights

Scopio — Buy & sell images on the largest Solana Photography NFT Marketplace. Find high-quality stock images & hire artists from around the world.
Scopio Labs — Scopio Labs is a provider of Full Field Morphology dedicated to unlocking the potential of imaging and AI in hematology. Uncovering actionable insights from vast amounts of data readily available in the average blood sample and bone marrow aspirate, Scopio's solutions will aim to showcase thousands of cells at scale in high resolution, toenable new hematology diagnostic methods.
Stake — Renters earn Cash back for rent. Building operators outperform the market. That's the Stake win-win. Find out how we're building the financial tools for the next generation of rentals.

Khwarizmi Ventures is a venture capital firm that seeks investments in startups with a passion for algorithms. It seeks to help create their vision, as they embark on a journey together that aligns their goals to improve quality of life using technology powered by algorithms. .

Investment focus

Software, E-Commerce, FinTech
Seed, Series A, Pre-Seed
Saudi Arabia, United Arab Emirates, Egypt

Portfolio highlights

Calo — Analyze your nutritional needs and subscribe to a convenient meal plan that's designed for you in under 2 minutes.
Yalla Plus — Yalla Plus offers QR-based digital menu solutions for restaurants, featuring integrated payments and easy menu management.
Mala'a Technologies — Make better financial decisions with Malaa. Manage your financials, track your expenses, take a loan or invest your money all from one app. Connect you bank accounts and start today

Hult Alumni Angels

Investment focus

Biopharma, Life Science, Biotechnology
Seed
Egypt

Portfolio highlights

Nawah Scientific — Nawah is MENA & Africa's first Cloud Lab providing Analytical and R&D services to the region's life science, food, agricultural and pharmaceutical sectors.

Investment Banking Boutique Since 1978

Investment focus

AgTech, Medical, Cannabis
Series A
Israel

Portfolio highlights

GemmaCert — The easy-to-use GC-PRO by GemmaCert for quick and accurate potency analysis of cannabis and hemp, including for THC, CBD, and CBG.

Rationalwave Capital Partners is a venture capital firm investing in technology companies both public and private. The firm is located in New York and founded by Mark Rosenblatt in 2003.

Investment focus

Machine Learning, Artificial Intelligence, Analytics
Seed, Pre-Seed, Funding Round
United States, Israel, Trinidad and Tobago

Portfolio highlights

Aromyx — Aromyx pioneers the creation of tastes and smells using a quantitative measurement system developed with biotechnology, data science, and AI.
Brij — With one-touch, BRIJ allows consumers to gain product info, care instructions and discounts while you gain a deeper understanding of your consumer. Apps, paper manuals and hassles not required.
BactoByte LTD — BactoByte aims to empower caregivers with one-hour bacterial diagnostics and antibiotic screening capability to improve outcomes, reduce mis-diagnostics, and lower health care costs.Based on a proprietary novel basic method, BactoByte’s assay delivers precise and cost-effective identification and direct antibiotics susceptibility testing with80-90% improvement of standard turnaround time.Time reduction, sensitivity, and specificity results in decreased mortality rates, fewer hospital days, and avoidance of associated costs of $1K-50K per patient.BactoByte has technology validation and partnerships with leading medical centers.

Investors by industry

Artificial intelligence